The pro-inflammatory cytokines such as IL-1 and TNFα activate GATA-2 and NF-κB, both of which inhibit EPO transcription by binding the EPO promoter [29, 31], leading to relative EPO deficiency in CKD patients. The gene discussed is EPO; the disease is chronic kidney disease.